Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2015
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Antithrombins (MeSH)
- Atrial Fibrillation (MeSH)
- Benzimidazoles (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Dabigatran (MeSH)
- Factor Xa Inhibitors (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- International Normalized Ratio (MeSH)
- Morpholines (MeSH)
- Pyrazoles (MeSH)
- Pyridones (MeSH)
- Rivaroxaban (MeSH)
- Stroke (MeSH)
- Thiophenes (MeSH)
- Vitamin K (MeSH)
- Warfarin (MeSH)
- beta-Alanine (MeSH)
published in
- American Heart Journal Journal